top of page

From the Press

Defeating depression through early risk detection and targeted medication

New personalised approaches to depression will either predict when a person is at risk to stop the condition in its tracks or target the illness with the optimum drug.

Defeating depression through early risk detection and targeted medication

Extreme Tech Startup Spotlight: Genetika+

This week in our Startup Spotlight blog series is our 2021 XTC Healthcare Category Winner – Genetika+: Precision Medicine with “Brain-in-a-Dish”!

Extreme Tech Startup Spotlight: Genetika+

How Brain-in-a-Dish Technology Can Impact the Treatment of MDD

The pathway to effective treatment of MDD may be improved by multifaceted diagnostic tools, including but not limited to brain-in-a-dish technology.

How Brain-in-a-Dish Technology Can Impact the Treatment of MDD

Genetika+ Announces CE Mark for NeuroKaire™ its AI-powered Tool to Optimize Depression Treatment

NeuroKaire demonstrates high accuracy in predicting drug response in patients suffering from major depressive disorder

Genetika+ Announces CE Mark for NeuroKaire™ its AI-powered Tool to Optimize Depression Treatment

'Brain-In-A-Dish' Helps Patients Find The Right Antidepressant

Through an Israeli startup's tech, physicians will soon be able to give patients a list of the antidepressants that would work best for them.

'Brain-In-A-Dish' Helps Patients Find The Right Antidepressant

KSM Research & Innovation And Genetika+ Partner To Seek AI Solutions For Personalization Of Depression Treatment

Kahn-Sagol-Maccabi (KSM) and Genetika+ form a research partnership to develop and validate AI that personalizes and speeds up an optimal depression treatment

KSM Research & Innovation And Genetika+ Partner To Seek AI Solutions For Personalization Of Depression Treatment

TheMarker Names Genetika+ One of the Top 20 Startups

ממחשוב קוונטי ועד צבעי מאכל, ומדיבוב סרטים עד גיוס עובדים. כמדי שנה, כתבי TheMarker בוחרים ב-20 חברות טכנולוגיה צעירות עם רעיונות גדולים

TheMarker Names Genetika+ One of the Top 20 Startups

Genetika+ Publication Featured in Future Medicine

Find out more about the extraordinary work happening at Genetika+ as we bring precision medicine into practice to optimize depression treatment

Genetika+ Publication Featured in Future Medicine

Genetika+ awarded up to €17.5M from European Commission's European Innovation Council (EIC) Accelerator for Europe’s high potential start-ups

Genetika+ Wins Prestigious European Funding to Bring Depression Drug Matching Platform to Market

Genetika+ awarded up to €17.5M from European Commission's European Innovation Council (EIC) Accelerator for Europe’s high potential start-ups

Dr. Daphna Laifenfeld Speaks at PMWC 2022

Genetika+ personalizes treatment in the mental health space, initially focusing on depression. The Genetika+ platform uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.

Dr. Daphna Laifenfeld Speaks at PMWC 2022

Genetika+ Wins the BioNJ BioPartnering Company & Pitch Presentation MedTech Award at the BioNJ 12th Annual Bio Partnering Conference

Co-Sponsored by J.P. Morgan and Johnson & Johnson, Genetika+ Gives Award Winning Presentation

Genetika+ Wins the BioNJ BioPartnering Company & Pitch Presentation MedTech Award at the BioNJ 12th Annual Bio Partnering Conference

CTO, Nadav Askari, Presents at Biomed Israel

Biomed Israel hosts leaders in the field to speak how AI and machine learning tools and techniques change the way we discover and develop drugs.

CTO, Nadav Askari, Presents at Biomed Israel

ScienceAbroad hosts Dr. Daphna Laifenfeld at Google Campus

Science Abroad hosts exposure workshop for biotech professionals all over Israel

ScienceAbroad hosts Dr. Daphna Laifenfeld at Google Campus

Female Led Genetika+ Grew and Gained Funding Through MassChallenge

How did a female-led startup from the MC18 Israel cohort turn their MassChallenge experience into a $10 million Series A funding round? Learn more about Genetika+ and its co-founders, Talia Cohen Solal and Daphna Laifenfeld, in our most recent case study.

Female Led Genetika+ Grew and Gained Funding Through MassChallenge

Genetika+ CEO Talia Cohen Solal Brings Precision Medicine to Brain Health

Depression, historically, has been treated by trial and error until a therapy with a positive and stable outcome can be identified. Genetika+ is changing that with precision, personalized testing that enables the right antidepressant to be selected for patients the first time.

Genetika+ CEO Talia Cohen Solal Brings Precision Medicine to Brain Health

Genetika+, Pioneer in Personalized Medicine for Psychiatry, Raises $10 Million in an Oversubscribed Series A

Proceeds to fund clinical trials and scale up in the U.S. market. New investment underscores the company’s promise to transform precision medicine and mental health.

Genetika+, Pioneer in Personalized Medicine for Psychiatry, Raises $10 Million in an Oversubscribed Series A

Combating Depression

A successful female entrepreneur, Talia Cohen Solal is an extremely driven, compassionate, and curious individual. As the CEO & Co-Founder of Genetika+, a biotech start-up specialized in developing new tools for personalized medicine in major depression, she is advancing treatment in a much-needed space. In this interview, she speaks on a range of topics – from a unique scientific approach to depression treatment, to her journey from academic to entrepreneur, from challenges faced in the industry, to her passion for entrepreneurship. Here are some excerpts from the interview.

Combating Depression

Discover 5 Top Healthcare Startups tackling Depression

Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the healthcare sector. This time, you get to discover 5 hand-picked startups tackling depression and mental health.

Discover 5 Top Healthcare Startups tackling Depression

Israeli biotech company Matricelf wins Calcalist’s StartUp+ competition

The company developed a platform for 3D printing of tissues and organs. Genetika+, which developed a personalized technology for digital health took second place; winners awarded monetary prizes and office space.

Israeli biotech company Matricelf wins Calcalist’s StartUp+ competition

Genetika+ has won Avon’s Women Startup Competition 2019

Avon Products, Inc. Reveals Winner of Women Startup Competition.

Genetika+ has won Avon’s Women Startup Competition 2019
bottom of page